Zhejiang Tianyu Pharmaceutical Co Ltd (300702) — Cash Flow Reinvestment Rate
Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a Cash Flow Reinvestment Rate of 0.30x as of September 2025, reinvesting CN¥70.00 Million (capex CN¥70.00 Million ) from operating cash flow of CN¥233.18 Million. Check how high is Zhejiang Tianyu Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Tianyu Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Zhejiang Tianyu Pharmaceutical Co Ltd across 9 annual periods. Explore 300702 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2024)
Year-by-year capital reinvestment analysis for Zhejiang Tianyu Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Zhejiang Tianyu Pharmaceutical Co Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.53x | CN¥182.60 Million | CN¥344.64 Million | CN¥168.95 Million | ▼ -36.6% |
| 2020 | 0.84x | CN¥519.93 Million | CN¥622.18 Million | CN¥506.05 Million | ▼ -36.4% |
| 2019 | 1.31x | CN¥562.13 Million | CN¥427.84 Million | CN¥354.10 Million | ▼ -62.4% |
| 2018 | 3.50x | CN¥274.89 Million | CN¥78.57 Million | CN¥179.89 Million | ▼ -26.8% |
| 2017 | 4.78x | CN¥423.04 Million | CN¥88.52 Million | CN¥112.54 Million | ▲ +88.4% |
| 2016 | 2.54x | CN¥417.94 Million | CN¥164.74 Million | CN¥107.44 Million | ▼ -40.2% |
| 2015 | 4.24x | CN¥62.59 Million | CN¥14.75 Million | CN¥62.59 Million | ▲ +326.7% |
| 2014 | 0.99x | CN¥79.99 Million | CN¥80.44 Million | CN¥79.99 Million | ▼ -42.2% |
| 2013 | 1.72x | CN¥68.31 Million | CN¥39.73 Million | CN¥68.31 Million | — |